Changes with insurance products have led to more costs being shifted to consumers and they are having very mixed emotions when faced with high-deductible health plans, explained Niteesh Choudhry, MD, PhD, associate professor of medicine at Harvard Medical School.
Changes with insurance products have led to more costs being shifted to consumers and they are having very mixed emotions when faced with high-deductible health plans, explained Niteesh Choudhry, MD, PhD, associate professor of medicine at Harvard Medical School.
Transcript (slightly modified)
How have insurance products been changing, and what is driving this change?
So I think the biggest change in health insurance is actually not new, it’s sort of a progressive change that’s happened over the past decade, which is increasing premiums, increasing deductibles, increasing out-of-pocket costs for patients.
I think there are lots of reasons for these changes, but certainly, at least in the employer market, it’s driven by the employers needing to reduce these costs. They have short-term incentives to reduce how much they spend on healthcare, and the easiest way to do that is to shift costs to consumers, to have consumers put more skin in the game and be cost-conscious about their choices.
What has been consumer reaction to new benefit designs like high-deductible health plans?
I think consumers have mixed emotions about these plans. So on one hand the idea that they face a very low premium at the time of signing up for a plan is very attractive, therefore many people sign up and believe that they’re healthy, or are unlikely to use or to need services. And that’s a very positive kind of reaction.
On the other side, there are really two facets. So the first is that people tend to not understand the plans, the plans are very complicated, and people who are most at risk—those with chronic conditions, those who have lower income, those who are of non-white race or ethnicity—tend to select and use the plans in ways that the plans are not really designed to, and this leads them to worse care.
So on the negative side, the plans cause confusion in and of themselves.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More